Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkmate 143 phase 3 randomized clinical trial
by Reardon, David A. (Author)
, Brandes, Alba A. (Author)
, Omuro, Antonio (Author)
, Mulholland, Paul (Author)
, Lim, Michael (Author)
, Wick, Antje (Author)
, Baehring, Joachim (Author)
, Ahluwalia, Manmeet S. (Author)
, Roth, Patrick (Author)
, Bähr, Oliver (Author)
, Phuphanich, Surasak (Author)
, Sepulveda, Juan Manuel (Author)
, De Souza, Paul (Author)
, Sahebjam, Solmaz (Author)
, Carleton, Michael (Author)
, Tatsuoka, Kay (Author)
, Taitt, Corina (Author)
, Zwirtes, Ricardo (Author)
, Sampson, John (Author)
, Weller, Michael (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource